KR102371663B1 - 아데노바이러스 벡터 - Google Patents

아데노바이러스 벡터 Download PDF

Info

Publication number
KR102371663B1
KR102371663B1 KR1020200008010A KR20200008010A KR102371663B1 KR 102371663 B1 KR102371663 B1 KR 102371663B1 KR 1020200008010 A KR1020200008010 A KR 1020200008010A KR 20200008010 A KR20200008010 A KR 20200008010A KR 102371663 B1 KR102371663 B1 KR 102371663B1
Authority
KR
South Korea
Prior art keywords
vector
dna
gene
cell
adenovirus
Prior art date
Application number
KR1020200008010A
Other languages
English (en)
Korean (ko)
Other versions
KR20210094353A (ko
Inventor
이준섭
원정택
신유빈
Original Assignee
코오롱생명과학 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코오롱생명과학 주식회사 filed Critical 코오롱생명과학 주식회사
Priority to KR1020200008010A priority Critical patent/KR102371663B1/ko
Priority to PCT/KR2021/000442 priority patent/WO2021149964A1/fr
Publication of KR20210094353A publication Critical patent/KR20210094353A/ko
Application granted granted Critical
Publication of KR102371663B1 publication Critical patent/KR102371663B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020200008010A 2020-01-21 2020-01-21 아데노바이러스 벡터 KR102371663B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020200008010A KR102371663B1 (ko) 2020-01-21 2020-01-21 아데노바이러스 벡터
PCT/KR2021/000442 WO2021149964A1 (fr) 2020-01-21 2021-01-13 Vecteur d'adénovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200008010A KR102371663B1 (ko) 2020-01-21 2020-01-21 아데노바이러스 벡터

Publications (2)

Publication Number Publication Date
KR20210094353A KR20210094353A (ko) 2021-07-29
KR102371663B1 true KR102371663B1 (ko) 2022-03-04

Family

ID=76992908

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200008010A KR102371663B1 (ko) 2020-01-21 2020-01-21 아데노바이러스 벡터

Country Status (2)

Country Link
KR (1) KR102371663B1 (fr)
WO (1) WO2021149964A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994132A (en) 1996-10-23 1999-11-30 University Of Michigan Adenovirus vectors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016205215B2 (en) * 2015-01-09 2021-03-11 Etubics Corporation Methods and compositions for combination immunotherapy
CA3010874A1 (fr) * 2016-01-15 2017-07-20 Etubics Corporation Methodes et compositions pour la vaccination contre le virus de la grippe
JP6797275B2 (ja) * 2016-07-15 2020-12-09 エトゥビクス コーポレーション フラビウイルスワクチン接種のための組成物及び方法
KR102039631B1 (ko) 2019-10-07 2019-11-01 의료법인 성광의료재단 U38, u40 및 u41의 일부 서열을 포함하는 재조합 단순 헤르페스 바이러스 셔틀 벡터의 제조 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994132A (en) 1996-10-23 1999-11-30 University Of Michigan Adenovirus vectors

Also Published As

Publication number Publication date
WO2021149964A1 (fr) 2021-07-29
KR20210094353A (ko) 2021-07-29

Similar Documents

Publication Publication Date Title
US20030170885A1 (en) Defective adenoviruses and corresponding complementation lines
JP6280084B2 (ja) 腫瘍溶解アデノウイルスベクター並びに前記に関連する方法および使用
US6451596B1 (en) Helper adenovirus vectors
CN107849111B (zh) 在免疫显性腺病毒抗原表位中具有突变的溶瘤腺病毒及其在癌症治疗中的用途
US6133028A (en) Defective adenoviruses and corresponding complementation lines
AU2013232101B2 (en) Selective cell targeting using adenovirus and chemical dimers
AU2022203504A1 (en) Oncolytic tumor viruses and methods of use
US6627190B2 (en) Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
AU2023255054A1 (en) Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
KR20130126589A (ko) 아데노바이러스 조립 방법
KR20200010498A (ko) 트랜스진을 보유하는 재조합 아데노바이러스
CN112805387A (zh) 用于制备病毒载体的组合物和方法
KR20190128634A (ko) 다중 트랜스진 재조합 아데노바이러스
US20200239859A1 (en) Life-cycle-defective adenovirus helper viruses, their production and use for producing raav
AU2016333996A1 (en) Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
KR20220019669A (ko) 플라스미드 시스템
AU780613B2 (en) Replication-competent anti-cancer vectors
KR20200140848A (ko) 복제 속성이 향상된 종양살상형 아데노바이러스 조성물
CN116348136A (zh) 新型冠状病毒重组刺突蛋白、编码该重组刺突蛋白的多核苷酸、包含多核苷酸的载体以及包含载体的用于预防或治疗冠状病毒感染的疫苗
KR102371663B1 (ko) 아데노바이러스 벡터
CN101440379B (zh) 选择性封闭肿瘤stat3的新型溶瘤腺病毒构建体的获得及用途
US20020102731A1 (en) Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof
RU2816645C1 (ru) Новый рекомбинантный шиповидный белок коронавируса, кодирующий его полинуклетид, вектор, содержащий полинуклетид, и вакцина для профилактики или лечения коронавирусной инфекции, содержащая вектор
KR20230008069A (ko) 아데노바이러스 발현 벡터, 및 제조를 위한 방법 및 세포주
KR20230061325A (ko) 신규한 코로나바이러스 재조합 스파이크 단백질, 이를 코딩하는 폴리뉴클레오티드, 상기 폴리뉴클레오티드를 포함하는 벡터 및 상기 벡터를 포함하는 코로나바이러스감염증 예방 또는 치료용 백신

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant